Clinical Trial Center North

Hamburg 20246

0 studies enrolling now · 1 studies all time

What they study most

Meningitis, Meningococcal

Studies at this site

• A Global Phase 3 Safety Study of 120 mcg rLP2086 Vaccine in Adolescents and Young Adults Aged 10 to 25 Years — Completed